Since heart failure is a distinct end-stage symptom of ARVC (Lu et al., 2022), the expression of cTnT and NT-proBNP was measured using the ELISA kit following pre-incubation with KA or ODN for 2 days. The gene discussed is TNNT2; the disease is arrhythmogenic right ventricular cardiomyopathy.